Integer Holdings (ITGR) EPS Estimated At $0.82; Hca Holdings (HCA)’s Sentiment Is 0.88

October 12, 2017 - By Peter Erickson

Analysts expect Integer Holdings Corporation (NYSE:ITGR) to report $0.82 EPS on October, 26.They anticipate $0.01 EPS change or 1.20% from last quarter’s $0.83 EPS. ITGR’s profit would be $25.76 million giving it 16.40 P/E if the $0.82 EPS is correct. After having $0.62 EPS previously, Integer Holdings Corporation’s analysts see 32.26% EPS growth. About 9,037 shares traded. Integer Holdings Corporation (NYSE:ITGR) has risen 24.88% since October 12, 2016 and is uptrending. It has outperformed by 8.18% the S&P500.

HCA Healthcare, Inc., formerly HCA Holdings, Inc., is a holding company. The company has market cap of $27.25 billion. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. It has a 10.06 P/E ratio. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups.

About 499,855 shares traded. HCA Healthcare Inc (HCA) has risen 7.08% since October 12, 2016 and is uptrending. It has underperformed by 9.62% the S&P500.

Analysts await HCA Healthcare Inc (NYSE:HCA) to report earnings on October, 26. They expect $1.63 EPS, up 1.24% or $0.02 from last year’s $1.61 per share. HCA’s profit will be $591.76 million for 11.51 P/E if the $1.63 EPS becomes a reality. After $1.75 actual EPS reported by HCA Healthcare Inc for the previous quarter, Wall Street now forecasts -6.86% negative EPS growth.

Ratings analysis reveals 83% of HCA’s analysts are positive. Out of 6 Wall Street analysts rating HCA, 5 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. The lowest target is $95.0 while the high is $103.0. The stock’s average target of $99 is 31.89% above today’s ($75.06) share price. HCA was included in 6 notes of analysts from October 13, 2016. The firm earned “Buy” rating on Wednesday, April 5 by Deutsche Bank. KeyBanc Capital Markets upgraded HCA Healthcare Inc (NYSE:HCA) on Thursday, October 13 to “Overweight” rating. Piper Jaffray initiated the shares of HCA in report on Wednesday, January 4 with “Overweight” rating. The firm has “Neutral” rating by Mizuho given on Wednesday, November 9. On Tuesday, January 17 the stock rating was upgraded by Avondale to “Mkt Outperform”. As per Friday, October 28, the company rating was maintained by RBC Capital Markets.

Consulta Ltd holds 14.86% of its portfolio in HCA Healthcare Inc for 1.40 million shares. Cryder Capital Partners Llp owns 368,626 shares or 13.75% of their US portfolio. Moreover, Chieftain Capital Management Inc. has 13.61% invested in the company for 2.23 million shares. The New York-based Brave Warrior Advisors Llc has invested 11.87% in the stock. Glenview Capital Management Llc, a New York-based fund reported 14.90 million shares.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.